检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
4期
448-449,452
,共3页
苏秀琼%陈奕霞%蓝建崇%刘丽芬
囌秀瓊%陳奕霞%藍建崇%劉麗芬
소수경%진혁하%람건숭%류려분
输血%血型%抗体筛查%输血反应
輸血%血型%抗體篩查%輸血反應
수혈%혈형%항체사사%수혈반응
blood transfusion%blood groups%antibody screening%transfusion reactions
目的:探讨输血前不规则血型抗体筛查对提高临床输血安全的意义。方法对2000例预输血患者进行抗体筛查,对不规则抗体筛查阳性的标本进行抗体特异性鉴定,统计不规则抗体的特异性和检出率。结果共筛出不规则抗体阳性者8例,阳性检出率为0.4%。其中血液系统疾病和肿瘤患者6例,占75.0%,高于其他疾病患者所占比例(2例,25.0%),比较差异有统计学意义(P<0.05)。不规则抗体阳性患者抗体特异性鉴定结果显示, Rh系统抗体占62.5%,MNS系统抗体(抗-M抗体)占37.5%。结论输血前对患者进行不规则抗体检测,有利于选择适合患者的血液,有效减少或避免溶血性输血反应的发生,保证了患者的输血安全。
目的:探討輸血前不規則血型抗體篩查對提高臨床輸血安全的意義。方法對2000例預輸血患者進行抗體篩查,對不規則抗體篩查暘性的標本進行抗體特異性鑒定,統計不規則抗體的特異性和檢齣率。結果共篩齣不規則抗體暘性者8例,暘性檢齣率為0.4%。其中血液繫統疾病和腫瘤患者6例,佔75.0%,高于其他疾病患者所佔比例(2例,25.0%),比較差異有統計學意義(P<0.05)。不規則抗體暘性患者抗體特異性鑒定結果顯示, Rh繫統抗體佔62.5%,MNS繫統抗體(抗-M抗體)佔37.5%。結論輸血前對患者進行不規則抗體檢測,有利于選擇適閤患者的血液,有效減少或避免溶血性輸血反應的髮生,保證瞭患者的輸血安全。
목적:탐토수혈전불규칙혈형항체사사대제고림상수혈안전적의의。방법대2000례예수혈환자진행항체사사,대불규칙항체사사양성적표본진행항체특이성감정,통계불규칙항체적특이성화검출솔。결과공사출불규칙항체양성자8례,양성검출솔위0.4%。기중혈액계통질병화종류환자6례,점75.0%,고우기타질병환자소점비례(2례,25.0%),비교차이유통계학의의(P<0.05)。불규칙항체양성환자항체특이성감정결과현시, Rh계통항체점62.5%,MNS계통항체(항-M항체)점37.5%。결론수혈전대환자진행불규칙항체검측,유리우선택괄합환자적혈액,유효감소혹피면용혈성수혈반응적발생,보증료환자적수혈안전。
Objective To investigate the value of irregular antibody screening in clinical blood transfusion. Methods 2 000 pre-transfusion patients underwent antibody screening were enrolled.Antibody specificity identifica-tion was performed for positive irregular specimens.Irregular antibody specificity and incidence were recorded.Re-sults There were 8 cases positive with irregular antibody,the positive rate was 0.4%,among which there were 6 patients with blood system diseases and tumors,accounting for 75.0%,higher than the proportion of patients with other diseases (2 cases,25.0%),and the difference was statistically significant (P<0.05).Irregular antibody speci-ficity identification indicated that Rh system antibodies accounted for 62.5%,and MNS system antibody (anti-M an-tibody)accounted for 37.5%.Conclusion Irregular antibody screening before blood transfusion might be helpful for choosing blood fit for patients,reducing or avoiding the occurrence of hemolytic transfusion reaction,and ensuing the safety of blood transfusion.